Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

por Gailhardou, Sophia, Skipetrova, Anna, Dayan, Gustavo H., Jezorwski, John, Saville, Melanie, Van der Vliet, Diane, Wartel, T. Anh
Publicado 2016

541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4(+) Count, and WHO Cl...

por Spinner, Christoph D, Rashbaum, Bruce, Mcdonald, Cheryl, Mussini, Cristina, Luo, Donghan, Jezorwski, John, Brown, Kimberley, Wong, Eric Y
Publicado 2018

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase...

por Lathouwers, Erkki, Wong, Eric Y, Brown, Kimberley, Baugh, Bryan, Ghys, Anne, Jezorwski, John, Mohsine, El Ghazi, Van Landuyt, Erika, Opsomer, Magda, De Meyer, Sandra
Publicado 2020

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

por Eron, Joseph J., Orkin, Chloe, Gallant, Joel, Molina, Jean-Michel, Negredo, Eugenia, Antinori, Andrea, Mills, Anthony, Reynes, Jacques, Van Landuyt, Erika, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Vanveggel, Simon, Opsomer, Magda
Publicado 2018